Adapthealth (AHCO)
NASDAQ:AHCO
Want to see AHCO full AI Analyst Report?
Total Valuation
AdaptHealth has a market cap or net worth of $1.43B. The enterprise value is $3.39B.
Market Cap$1.43B
Enterprise Value$3.39B
Share Statistics
AdaptHealth has 136,054,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding136,054,150
Owned by Insiders15.03%
Owned by Institutions29.99%
Financial Efficiency
AdaptHealth’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is 5.07%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)5.07%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee309.03K
Profits Per Employee-6.29K
Employee Count10,500
Asset Turnover0.75
Inventory Turnover17.69
Valuation Ratios
The current PE Ratio of AdaptHealth is ―. AdaptHealth’s PEG ratio is 0.10.
PE Ratio―
PS Ratio0.41
PB Ratio0.89
Price to Fair Value0.89
Price to FCF6.14
Price to Operating Cash Flow2.38
PEG Ratio0.10
Income Statement
In the last 12 months, AdaptHealth had revenue of 3.24B and earned -70.79M in profits. Earnings per share was -0.52.
Revenue3.24B
Gross Profit568.56M
Operating Income186.27M
Pretax Income-15.15M
Net Income-70.79M
EBITDA503.64M
Earnings Per Share (EPS)-0.52
Cash Flow
In the last 12 months, operating cash flow was 599.97M and capital expenditures -408.01M, giving a free cash flow of 191.95M billion.
Operating Cash Flow599.97M
Free Cash Flow191.95M
Free Cash Flow per Share1.41
Dividends & Yields
AdaptHealth pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.39
52-Week Price Change17.79%
50-Day Moving Average11.66
200-Day Moving Average10.14
Relative Strength Index (RSI)33.79
Average Volume (3m)1.48M
Important Dates
AdaptHealth upcoming earnings date is Aug 11, 2026, After Close (Confirmed).
Last Earnings DateMay 5, 2026
Next Earnings DateAug 11, 2026
Ex-Dividend Date―
Financial Position
AdaptHealth as a current ratio of 1.02, with Debt / Equity ratio of 132.75%
Current Ratio1.02
Quick Ratio0.81
Debt to Market Cap1.29
Net Debt to EBITDA3.57
Interest Coverage Ratio1.76
Taxes
In the past 12 months, AdaptHealth has paid 50.88M in taxes.
Income Tax50.88M
Effective Tax Rate-3.36
Enterprise Valuation
AdaptHealth EV to EBITDA ratio is 6.24, with an EV/FCF ratio of 14.33.
EV to Sales0.97
EV to EBITDA6.24
EV to Free Cash Flow14.33
EV to Operating Cash Flow5.22
Balance Sheet
AdaptHealth has $47.96M in cash and marketable securities with $2.00B in debt, giving a net cash position of -$1.95B billion.
Cash & Marketable Securities$47.96M
Total Debt$2.00B
Net Cash-$1.95B
Net Cash Per Share-$14.35
Tangible Book Value Per Share-$8.14
Margins
Gross margin is 5.38%, with operating margin of 5.74%, and net profit margin of -2.18%.
Gross Margin5.38%
Operating Margin5.74%
Pretax Margin-0.47%
Net Profit Margin-2.18%
EBITDA Margin15.52%
EBIT Margin2.79%
Analyst Forecast
The average price target for AdaptHealth is $13.93, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$13.93
Price Target Upside10.02% Upside
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast1.24%
EPS Growth Forecast-202.42%